Streptozotocin-Induced Diabetic Rat-Derived Bone Marrow Mesenchymal Stem Cells Have Impaired Abilities in Proliferation, Paracrine, Antiapoptosis, and Myogenic Differentiation

被引:77
作者
Jin, P. [1 ,3 ]
Zhang, X. [1 ]
Wu, Y. [1 ,3 ]
Li, L. [3 ]
Yin, Q. [1 ]
Zheng, L. [1 ]
Zhang, H. [2 ]
Sun, C. [1 ]
机构
[1] Wenzhou Med Coll, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, Wenzhou 325000, Peoples R China
[2] Minist Hlth, Res Ctr Cardiac Regenerat Med, Beijing, Peoples R China
[3] Wenzhou Med Coll, Wenzhou 325000, Peoples R China
关键词
ENDOTHELIAL GROWTH-FACTOR; DEPRIVATION; TRANSPLANTATION; INHIBITION; SENESCENCE; EXPRESSION; APOPTOSIS; HYPOXIA; LEVEL; MODEL;
D O I
10.1016/j.transproceed.2010.05.145
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Diabetes has been widely recognized as a major risk factor for cardiovascular disease. With the development of the regenerative medicine, autologous bone marrow-derived mesenchymal stem cells (BMSCs), transplantation can effectively improve cardiac function after myocardial infarction. However, the BMSCs used in most previous studies are derived from young or normal donors. Little is know about the biological characters change of BMSCs in diabetes mellitus. Methods. BMSCs were taken from the streptozotocin (STZ)-induced diabetic rats and normal control rats. Cell proliferation was evaluated by CCK-8 assay. Production of vascular endothelial growth factor (VEGF) and insulin-like growth factor (IGF)-1 were measured by enzyme-linked immunosorbent assay. Apoptosis under hypoxia and serum deprivation culture conditions were detected by Hoechst 33342 stain and flow cytometry. Myogenic differentiation, induced by 5-azacytidine was assessed by using immunocytochemical staining for the expression of sarcomeric a-actin and desmin. Results. Diabetic rat models were successfully induced by intraperitoneal injection of STZ. The proliferative abilities of BMSCs derived from diabetic rats decreased significantly compared with that from normal rats (P < .05). Similar results were also presented in the cytokines (VEGF and IGF-1) release (P = .02 and P < .01, respectively) that the ability of antiapoptosis and myogenic differentiation decreased obviously between diabetes group and the normal control group (P < .01). Conclusion. BMSCs from STZ-induced diabetic rats could be successfully harvested and expanded in vitro culture condition; their morphology was very similar to normal control group, with minor changes. However, the proliferative and differentiation properties of diabetic BMSCs, as well as cytokine release and antiapoptosis ability, were significantly impaired.
引用
收藏
页码:2745 / 2752
页数:8
相关论文
共 28 条
  • [1] High glucose-induced replicative senescence: point of no return and effect of telomerase
    Blazer, S
    Khankin, E
    Segev, Y
    Ofir, R
    Yalon-Hacohen, M
    Kra-Oz, Z
    Gottfried, Y
    Larisch, S
    Skorecki, KL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (01) : 93 - 101
  • [2] Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis
    Chen, Jinghai
    Baydoun, Anwar R.
    Xu, Ruixia
    Deng, Linzi
    Liu, Xuebin
    Zhu, Weiquan
    Shi, Linhui
    Cong, Xiangfeng
    Hu, Shengshou
    Chen, Xi
    [J]. STEM CELLS, 2008, 26 (01) : 135 - 145
  • [3] Specific receptor subtype mediation of LPA-induced dual effects in cardiac fibroblasts
    Chen, Jinghai
    Han, Yu
    Zhu, Weiquan
    Ma, Rui
    Han, Bianmei
    Cong, Xiangfeng
    Hu, Shengshou
    Chen, Xi
    [J]. FEBS LETTERS, 2006, 580 (19) : 4737 - 4745
  • [4] Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states - A possible explanation for impaired collateral formation in cardiac tissue
    Chou, E
    Suzuma, I
    Way, KJ
    Opland, D
    Clermont, AC
    Naruse, K
    Suzuma, K
    Bowling, NL
    Vlahos, CJ
    Aiello, LP
    King, GL
    [J]. CIRCULATION, 2002, 105 (03) : 373 - 379
  • [5] Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus - United Kingdom prospective diabetes study 78
    Cull, Carole A.
    Jensen, Christine C.
    Retnakaran, Ravi
    Holman, Rury R.
    [J]. CIRCULATION, 2007, 116 (19) : 2119 - 2126
  • [6] Vascular endothelial growth factor and diabetes - The agonist versus antagonist paradox
    Duh, E
    Aiello, LP
    [J]. DIABETES, 1999, 48 (10) : 1899 - 1906
  • [7] In Vitro Effects of Low-Level Laser Irradiation for Bone Marrow Mesenchymal Stem Cells: Proliferation, Growth Factors Secretion and Myogenic Differentiation
    Hou, Jian-Feng
    Zhang, Hao
    Yuan, Xin
    Li, Jun
    Wei, Ying-Jie
    Hu, Sheng-shou
    [J]. LASERS IN SURGERY AND MEDICINE, 2008, 40 (10) : 726 - 733
  • [8] Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium
    Jiang, Shujia
    Haider, Husnain Kh
    Ahmed, Rafeeq P. H.
    Idris, Niagara M.
    Salim, Asmat
    Ashraf, Muhammad
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (03) : 582 - 596
  • [9] Pluripotency of mesenchymal stem cells derived from adult marrow
    Jiang, Yuehua
    Jahagirdar, Balkrishna N.
    Reinhardt, R. Lee
    Schwartz, Robert E.
    Keene, C. Dirk
    Ortiz-Gonzalez, Xilma R.
    Reyes, Morayma
    Lenvik, Todd
    Lund, Troy
    Blackstad, Mark
    Du, Jingbo
    Aldrich, Sara
    Lisberg, Aaron
    Low, Walter C.
    Lergaespada, David A.
    Verfaillie, Catherine M.
    [J]. Nature, 2002, 418 (6893) : 41 - 49
  • [10] Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes
    Kang, Lina
    Chen, Qin
    Wang, Lian
    Gao, Ling
    Meng, Kui
    Chen, Junhao
    Ferro, Albert
    Xu, Biao
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (10) : e47 - e56